182 related articles for article (PubMed ID: 35700788)
21. Associations between exposure to brominated flame retardants and metabolic syndrome and its components in U.S. adults.
Che Z; Jia H; Chen R; Pan K; Fan Z; Su C; Wu Z; Zhang T
Sci Total Environ; 2023 Feb; 858(Pt 2):159935. PubMed ID: 36336051
[TBL] [Abstract][Full Text] [Related]
22. Essential metals modified the effects of polycyclic aromatic hydrocarbons on the metabolic syndrome: Mediation effects of miRNA.
Deng Q; Wei Y; Liu K; Wu D; Zhu X; Xu M; Bai Y
Sci Total Environ; 2024 Jan; 906():167506. PubMed ID: 37788778
[TBL] [Abstract][Full Text] [Related]
23. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
[TBL] [Abstract][Full Text] [Related]
24. Cardiometabolic traits mediated the relationship from urinary polycyclic aromatic hydrocarbons metabolites to heart rate variability reduction: A community-based study.
Guo Y; Cao L; Zhou Y; Xiao L; Zhang X; Yuan J; Chen W
Environ Pollut; 2018 Dec; 243(Pt A):28-36. PubMed ID: 30172123
[TBL] [Abstract][Full Text] [Related]
25. Exposure to Organophosphate esters and metabolic syndrome in adults.
Luo K; Zhang R; Aimuzi R; Wang Y; Nian M; Zhang J
Environ Int; 2020 Oct; 143():105941. PubMed ID: 32679393
[TBL] [Abstract][Full Text] [Related]
26. Association of serum water-soluble vitamin exposures with the risk of metabolic syndrome: results from NHANES 2003-2006.
Pei X; Yao J; Ran S; Lu H; Yang S; Zhang Y; Wang M; Shi H; Tan A
Front Endocrinol (Lausanne); 2023; 14():1167317. PubMed ID: 37251666
[TBL] [Abstract][Full Text] [Related]
27. Urinary phthalate metabolites and metabolic syndrome in U.S. adolescents: Cross-sectional results from the National Health and Nutrition Examination Survey (2003-2014) data.
Gaston SA; Tulve NS
Int J Hyg Environ Health; 2019 Mar; 222(2):195-204. PubMed ID: 30297147
[TBL] [Abstract][Full Text] [Related]
28. Exposure to polycyclic aromatic hydrocarbon-induced oxidative stress in Shiraz, Iran: urinary levels, health risk assessment and mediation effect of MDA on the risk of metabolic syndromes.
Shahsavani S; Fararouei M; Soveid M; Dehghani M; Hoseini M
Int Arch Occup Environ Health; 2022 Jul; 95(5):1043-1058. PubMed ID: 34997324
[TBL] [Abstract][Full Text] [Related]
29. Contributions of dietary, demographic, disease, lifestyle and other factors in explaining variabilities in concentrations of selected monohydroxylated polycyclic aromatic hydrocarbons in urine: Data for US children, adolescents, and adults.
Jain RB
Environ Pollut; 2020 Nov; 266(Pt 1):115178. PubMed ID: 32688109
[TBL] [Abstract][Full Text] [Related]
30. Prenatal exposure to polycyclic aromatic hydrocarbons and cognition in early childhood.
Sun B; Wallace ER; Ni Y; Loftus CT; Szpiro A; Day D; Barrett ES; Nguyen RHN; Kannan K; Robinson M; Bush NR; Sathyanarayana S; Mason A; Swan SH; Trasande L; Karr CJ; LeWinn KZ
Environ Int; 2023 Aug; 178():108009. PubMed ID: 37331181
[TBL] [Abstract][Full Text] [Related]
31. Studying the effects of polycyclic aromatic hydrocarbons on peripheral arterial disease in the United States.
Xu X; Hu H; Kearney GD; Kan H; Sheps DS
Sci Total Environ; 2013 Sep; 461-462():341-7. PubMed ID: 23747551
[TBL] [Abstract][Full Text] [Related]
32. Associations of individual and mixture exposure to volatile organic compounds with metabolic syndrome and its components among US adults.
Tan L; Liu Y; Liu J; Liu Z; Shi R
Chemosphere; 2024 Jan; 347():140683. PubMed ID: 37952817
[TBL] [Abstract][Full Text] [Related]
33. Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea.
Park B; Kim B; Kim CH; Oh HJ; Park B
Ecotoxicol Environ Saf; 2024 May; 276():116310. PubMed ID: 38614002
[TBL] [Abstract][Full Text] [Related]
34. Association between polycyclic aromatic hydrocarbons exposure with red cell width distribution and ischemic heart disease: insights from a population-based study.
Wu P
Sci Rep; 2024 Jan; 14(1):196. PubMed ID: 38168482
[TBL] [Abstract][Full Text] [Related]
35. Association between polycyclic aromatic hydrocarbons and osteoporosis: data from NHANES, 2005-2014.
Duan W; Meng X; Sun Y; Jia C
Arch Osteoporos; 2018 Oct; 13(1):112. PubMed ID: 30334129
[TBL] [Abstract][Full Text] [Related]
36. Urinary Concentrations of Polycyclic Aromatic Hydrocarbon Metabolites in
Lopes AB; Metzdorf M; Metzdorf L; Sousa MPR; Kavalco C; Etemadi A; Pritchett NR; Murphy G; Calafat AM; Abnet CC; Dawsey SM; Fagundes RB
Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):331-337. PubMed ID: 29263183
[No Abstract] [Full Text] [Related]
37. Polycyclic aromatic hydrocarbon metabolite levels and pediatric allergy and asthma in an inner-city cohort.
Miller RL; Garfinkel R; Lendor C; Hoepner L; Li Z; Romanoff L; Sjodin A; Needham L; Perera FP; Whyatt RM
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):260-7. PubMed ID: 20003063
[TBL] [Abstract][Full Text] [Related]
38. Association of chronic kidney disease with exposure to polycyclic aromatic hydrocarbons in the US population.
Rahman HH; Niemann D; Munson-McGee SH
Environ Sci Pollut Res Int; 2022 Apr; 29(16):24024-24034. PubMed ID: 34822075
[TBL] [Abstract][Full Text] [Related]
39. Associations of urinary polycyclic aromatic hydrocarbon metabolites and blood pressure with the mediating role of cytokines: A panel study among children.
Liu M; Zhao L; Liu L; Guo W; Yang H; Yu J; Chen S; Li M; Fang Q; Lai X; Yang L; Zhu R; Zhang X
Environ Sci Pollut Res Int; 2022 Oct; 29(49):74921-74932. PubMed ID: 35648342
[TBL] [Abstract][Full Text] [Related]
40. Dietary phylloquinone intakes and metabolic syndrome in US young adults.
Pan Y; Jackson RT
J Am Coll Nutr; 2009 Aug; 28(4):369-79. PubMed ID: 20368375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
